Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Riot Platforms, Inc. Capital/Financing Update 2013

May 30, 2013

30793_rns_2013-05-30_bc23d48e-4a5b-4e38-9ed4-d6c291fdd144.zip

Capital/Financing Update

Open in viewer

Opens in your device viewer

8-K 1 appy_8k.htm FORM 8-K appy_8k.htm Licensed to: Edgar Technology & Business Services Inc Document Created using EDGARizerAgent 5.4.3.1 Copyright 1995 - 2009 Thomson Reuters. All rights reserved.

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported) May 30, 2013

Venaxis, Inc.
(Exact name of Registrant as specified in its charter)
Colorado 001-33675 84-155338
(State or other jurisdiction of incorporation or organization) (Commission File Number) (I.R.S. Employer Identification No.)
1585 South Perry Street Castle Rock, Colorado 80104
(Address of principal executive offices) (Zip Code)

Registrant’s telephone number, including area code: (303) 794-2000

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

EFPlaceholder o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 8.01 Other Events.

On May 30, 2013, the Company issued a press release announcing the closing of its previously announced underwritten public offering of shares of its Common Stock and Warrants, a copy of which is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits

(d) Exhibits.

1.1 Purchase Agreement by and between Venaxis, Inc. and Piper Jaffray & Co. dated May 23, 2013.

4.1 Common Stock Purchase Warrant Agreement by and between Venaxis, Inc. and Corporate Stock Transfer, Inc. dated May 30, 2013.

99.1 Press Release of Venaxis, Inc. entitled “Venaxis Closes Underwritten Public Offering, Including Full Over-Allotment,” issued May 30, 2013.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

/s/ Jeffrey G. McGonegal
Name: Jeffrey G. McGonegal
Title: Chief Financial Officer